Eric Venker Roivant Sciences Ltd. (ROIV) insider trading activity

ROIV Quotes by TradingView

Eric Venker is President & Immunovant CEO of Roivant Sciences Ltd.. Currently has a direct ownership of 1.65 Million shares of ROIV, which is worth approximately $33.6 Million. The most recent transaction as insider was on Apr 25, 2022, when has been sold 5,107 shares (Common Shares) at a price of $3.84 per share, resulting in proceeds of $19,611. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.65M
9.94% 3M change
123.3% 12M change
Total Value Held $33.6 Million

Eric Venker Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 25 2022
SELL
Open market or private sale
$19,611 $3.84 p/Share
5,107 Reduced 0.4%
1,269,413 Common Shares
Mar 30 2022
SELL
Payment of exercise price or tax liability
$71,536 $4.74 p/Share
15,092 Reduced 1.17%
1,274,520 Common Shares
Mar 30 2022
SELL
Open market or private sale
$93,586 $4.84 p/Share
19,336 Reduced 1.48%
1,289,612 Common Shares
Mar 25 2022
SELL
Open market or private sale
$405,028 $5.06 p/Share
80,045 Reduced 5.76%
1,308,948 Common Shares

Also insider at

IMVT
Immunovant, Inc. Healthcare
Chief Executive Officer
EV

Eric Venker

President & Immunovant CEO
London, X0

Track Institutional and Insider Activities on ROIV

Follow Roivant Sciences Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ROIV shares.

Notify only if

Insider Trading

Get notified when an Roivant Sciences Ltd. insider buys or sells ROIV shares.

Notify only if

News

Receive news related to Roivant Sciences Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ROIV